7-BROMO-3-(2,2-DIMETHYL-1-OXOPROPOXY)-5,6-EPOXYDIHYDRO-3'H-CYCLOPROP(15,16)ANDROST-15-EN-17-ONE, (3.BETA.,5.BETA.,6.BETA.,7.ALPHA.,15.ALPHA.,16.ALPHA.)-
UNII TBV9ZC4YBW
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-bromo-3-(2,2-dimethyl-1-oxopropoxy)-5,6-epoxydihydro-3'h-cycloprop(15,16)androst-15-en-17-one, (3.beta.,5.beta.,6.beta.,7.alpha.,15.alpha.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TBV9ZC4YBW.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 863329-69-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H35BrO4 NJOBSSPFBRMYST-DNLFMSLGSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-bromo-3-(2,2-dimethyl-1-oxopropoxy)-5,6-epoxydihydro-3'h-cycloprop(15,16)androst-15-en-17-one, (3.beta.,5.beta.,6.beta.,7.alpha.,15.alpha.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.